ES2069272T3 - Hexapeptidos con grupos esteres sulfato. - Google Patents
Hexapeptidos con grupos esteres sulfato.Info
- Publication number
- ES2069272T3 ES2069272T3 ES91901058T ES91901058T ES2069272T3 ES 2069272 T3 ES2069272 T3 ES 2069272T3 ES 91901058 T ES91901058 T ES 91901058T ES 91901058 T ES91901058 T ES 91901058T ES 2069272 T3 ES2069272 T3 ES 2069272T3
- Authority
- ES
- Spain
- Prior art keywords
- elevated
- ala
- pro
- sub
- square
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/595—Gastrins; Cholecystokinins [CCK]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/595—Gastrins; Cholecystokinins [CCK]
- C07K14/5955—Gastrins; Cholecystokinins [CCK] at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Led Devices (AREA)
- Hydroponics (AREA)
- Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
COMPUESTOS DE LA FORMULA (I), EN DONDE M ES MET, DMET, MEMET, METO, AHX, DAHX, MEAHX, LEU, MELEU, PRO, ILE, MEILE, ALA O LYS; G ES GLY, DALA, PRO, ALA, (BETA)ALA O SAR; W ES TRP, METRP, ALA O NAL; X ES MET, MEMET, METO, AHX, MEAHX, LEU, MELEU, PRO, ILE, MEILE, ALA O LYS; J ES ASP, DASP, MEASP, ALA O ASN; F ELEVADO 1 ES (S)-NH, (R)-NH, (S)-R ELEVADO 1N O (R)-R (AL CUADRADO) N; F (AL CUADRADO) ES H , CL, I, BR, F, NO SUB 2, NH SUB 2, R ELEVADO 3 O OR ELEVADO 4; Z ES NH SUB 2, NHR ELEVADO 5 O NR ELEVADO 5R ELEVADO 6; R ELEVADO 1, R (AL CUADRADO) , R ELEVADO 3, R ELEVADO 5 Y R ELEVADO 6 SON C1 A 6 ALQUILO; Y R ELEVADO 4 ES H O C1 A 6 ALQUILO Y LAS SALES FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS, QUE SON NUEVOS Y UTILES COMO PRODUCTOS FARMACEUTICOS. EN PARTICULAR, SON UTILES PARA EL TRATAMIENTO DE LA OBESIDAD Y PARA ESTIMULAR LA CONTRACCION DE LA VESICULA BILIAR.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44127589A | 1989-11-27 | 1989-11-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2069272T3 true ES2069272T3 (es) | 1995-05-01 |
Family
ID=23752246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES91901058T Expired - Lifetime ES2069272T3 (es) | 1989-11-27 | 1990-11-16 | Hexapeptidos con grupos esteres sulfato. |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0495013B1 (es) |
| JP (1) | JPH05500962A (es) |
| KR (1) | KR927003630A (es) |
| AT (1) | ATE119544T1 (es) |
| AU (1) | AU644128B2 (es) |
| CA (1) | CA2030720A1 (es) |
| DE (1) | DE69017704T2 (es) |
| DK (1) | DK0495013T3 (es) |
| ES (1) | ES2069272T3 (es) |
| FI (1) | FI922404L (es) |
| HU (2) | HU00168A9 (es) |
| IE (1) | IE66837B1 (es) |
| IL (1) | IL96465A (es) |
| LV (1) | LV11623A (es) |
| NO (1) | NO922094L (es) |
| NZ (1) | NZ236167A (es) |
| PT (1) | PT95996B (es) |
| WO (1) | WO1991008225A1 (es) |
| ZA (1) | ZA909415B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5502164A (en) * | 1989-11-27 | 1996-03-26 | Fisons Corporation | Peptide compounds having therapeutic activity |
| MX9207458A (es) * | 1991-12-20 | 1993-11-01 | Fisons Corp | Compuestos de peptido que tienen actividad terapeutica. |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR6915336D0 (pt) * | 1969-05-27 | 1973-03-13 | Squibb & Sons Inc | Reptidios contendo tirosina-o-sulfato |
| DD128973B1 (de) * | 1976-11-29 | 1979-11-28 | Hartmut Niedrich | Verfahren zur herstellung von peptiden,die tyrosinsulfat enthalten |
| US4217353A (en) * | 1978-05-19 | 1980-08-12 | E. I. Du Pont De Nemours And Company | Method for inducing anorexia |
| NZ218607A (en) * | 1985-12-19 | 1989-10-27 | Pennwalt Corp | Tri-to acta-peptides with sulphate ester groups: obesity treatment |
| US5086042A (en) * | 1985-12-19 | 1992-02-04 | Fisons Corporation | Peptides with sulfate ester groups |
| IE873084L (en) * | 1986-11-18 | 1988-05-18 | Pfizer Hospital Prod | Peptides with sulfate ester groups |
| US4808701A (en) * | 1987-03-30 | 1989-02-28 | Hoffmann-La Roche Inc. | Cyclic peptides having appetite regulating activity |
-
1990
- 1990-11-16 ES ES91901058T patent/ES2069272T3/es not_active Expired - Lifetime
- 1990-11-16 DE DE69017704T patent/DE69017704T2/de not_active Expired - Fee Related
- 1990-11-16 FI FI922404A patent/FI922404L/fi not_active Application Discontinuation
- 1990-11-16 WO PCT/US1990/006739 patent/WO1991008225A1/en not_active Ceased
- 1990-11-16 EP EP91901058A patent/EP0495013B1/en not_active Expired - Lifetime
- 1990-11-16 KR KR1019920701235A patent/KR927003630A/ko not_active Ceased
- 1990-11-16 DK DK91901058.7T patent/DK0495013T3/da active
- 1990-11-16 AU AU69644/91A patent/AU644128B2/en not_active Ceased
- 1990-11-16 AT AT91901058T patent/ATE119544T1/de not_active IP Right Cessation
- 1990-11-16 JP JP3501490A patent/JPH05500962A/ja active Pending
- 1990-11-20 NZ NZ236167A patent/NZ236167A/en unknown
- 1990-11-23 IE IE423990A patent/IE66837B1/en not_active IP Right Cessation
- 1990-11-23 CA CA002030720A patent/CA2030720A1/en not_active Abandoned
- 1990-11-23 ZA ZA909415A patent/ZA909415B/xx unknown
- 1990-11-26 IL IL9646590A patent/IL96465A/en not_active IP Right Cessation
- 1990-11-26 PT PT95996A patent/PT95996B/pt not_active IP Right Cessation
-
1992
- 1992-05-26 NO NO92922094A patent/NO922094L/no unknown
-
1995
- 1995-06-07 HU HU95P/P00168P patent/HU00168A9/hu unknown
- 1995-06-12 HU HU95P/P00189P patent/HU211694A9/hu unknown
-
1996
- 1996-03-07 LV LV960068A patent/LV11623A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2030720A1 (en) | 1991-05-28 |
| IE904239A1 (en) | 1991-06-05 |
| FI922404A7 (fi) | 1992-05-26 |
| AU6964491A (en) | 1991-06-26 |
| WO1991008225A1 (en) | 1991-06-13 |
| AU644128B2 (en) | 1993-12-02 |
| HU211694A9 (en) | 1995-12-28 |
| NO922094D0 (no) | 1992-05-26 |
| NO922094L (no) | 1992-07-08 |
| JPH05500962A (ja) | 1993-02-25 |
| IL96465A (en) | 1994-12-29 |
| PT95996B (pt) | 1998-01-30 |
| ATE119544T1 (de) | 1995-03-15 |
| DE69017704D1 (de) | 1995-04-13 |
| DE69017704T2 (de) | 1995-07-20 |
| EP0495013A1 (en) | 1992-07-22 |
| HU00168A9 (en) | 1995-07-28 |
| PT95996A (pt) | 1991-09-13 |
| FI922404A0 (fi) | 1992-05-26 |
| KR927003630A (ko) | 1992-12-18 |
| DK0495013T3 (da) | 1995-07-24 |
| LV11623A (lv) | 1996-12-20 |
| FI922404L (fi) | 1992-05-26 |
| NZ236167A (en) | 1991-12-23 |
| ZA909415B (en) | 1991-11-27 |
| EP0495013B1 (en) | 1995-03-08 |
| IE66837B1 (en) | 1996-02-07 |
| IL96465A0 (en) | 1991-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Low et al. | Chemical characterization of thymosin beta 4. | |
| DE69105270T2 (de) | D-2-alkyltryptophan enthaltende biologisch aktive peptide. | |
| DE69730787T2 (de) | Verfahren zur Herstellung von PTH- und PTrP-analogen Verbindungen | |
| PE7898A1 (es) | Peptidos compuestos que se ligan al receptor de trombopoietina | |
| ES526201A0 (es) | Un procedimiento para preparar un peptido que tiene influencia sobre la funcion de la glandula pituitaria | |
| Hirata et al. | Structures and actions of Mytilus inhibitory peptides | |
| Cropper et al. | Structure, bioactivity, and cellular localization of myomodulin B: a novel Aplysia peptide | |
| YU41914B (en) | Process for obtaining new tri peptides | |
| MX9301535A (es) | Material proteinaceo biologicamente activo aislado y purificado. | |
| Lebl et al. | Synthesis of cyclic peptides by solid phase methodology | |
| CA1187869A (en) | Deca- undeca- dodeca and tridecapeptides with thymic activity | |
| Linsenmayer | Temporal and spatial transitions in collagen types during embryonic chick limb development: II. Comparison of the embryonic cartilage collagen molecule with that from adult cartilage | |
| ES2069272T3 (es) | Hexapeptidos con grupos esteres sulfato. | |
| BR9301436A (pt) | Peptideo,processo para a sua preparacao,aplicacao desse peptideo e agente farmaceutico | |
| ES8103029A1 (es) | Un procedimiento para la preparacion de un peptido | |
| DE69025763T2 (de) | Vasodilatierende und immunsupprimierende peptide | |
| KR940011479A (ko) | 시클로 펩티드 | |
| DE361977T1 (de) | Peptide mit t-zellensuppressor-wirksamkeit. | |
| MX9400072A (es) | Agentes antiinflamatorios derivados de difluoropentapeptido. | |
| DE68905097D1 (de) | Peptid-molekuele, wirksam gegen gram-positive keime. | |
| KR950011466A (ko) | 선형 결합 억제제 | |
| RU95113498A (ru) | Линейные или циклические олигопептиды, обладающие сродством к опиоидным рецепторам, фармацевтическая композиция, способ лечения | |
| RU95120588A (ru) | Циклогексапептиды, их смеси, способ их получения и применения | |
| Wieland et al. | 4Phe-(6) Val-antamanide, an antitoxic cyclodecapeptide with C (2) symmetry. | |
| KR970015597A (ko) | 비오틴 유도체 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 495013 Country of ref document: ES |